default author photo

Jianji Pan

Fujian Medical University - Fujian Provincial Hospital

Fuzhou

China

SCHOLARLY PAPERS

2

DOWNLOADS

231

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

JUPITOR-02: Randomized, Double-Blind, Phase 3 Study of Toripalimab or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma

Number of pages: 35 Posted: 16 Apr 2021
Prince of Wales Hospital - State Key Laboratory of Oncology in South China, Prince of Wales Hospital - State Key Laboratory of Oncology in South China, Guangzhou Medical University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Huazhong University of Science and Technology - Cancer Center, Guangdong Medical University - Affiliated Hospital, Jiangxi Cancer Hospital - Department of Head and neck radiotherapy, Central South University - Hunan Cancer Hospital, Fujian Provincial Cancer Hospital, Fujian Medical University - Fujian Provincial Hospital, People’s Hospital of Guangxi Zhuang Autonomous Region, Sichuan University - West China Hospital, Central South University - Second Xiangya Hospital, Taichung Veterans General Hospital, Shantou University Medical College - Cancer Hospital, Jiangsu Cancer Hospital, Chang Gung University - Chang Gung Memorial Hospital, National Cancer Centre Singapore, Southern Medical University - Department of Oncology, Chinese Academy of Medical Sciences - Peking Union Medical College, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Sun Yat-sen University (SYSU) - Fifth Affiliated Hospital, Huazhong University of Science and Technology - Department of Oncology, Shanghai Jiao Tong University (SJTU) - Shanghai General Hospital, Fujian Medical University - Union Hospital, Hebei Medical University - Fourth Hospital, Hainan Medical University - Hainan General Hospital, Liuzhou Worker’s Hospital, China Medical University - College of Medicine, National Chiao Tung University - Institute of Clinical Medicine, National Cheng Kung University - Department of Internal Medicine, Tan Tock Seng Hospital, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, TopAlliance Biosciences and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 179 (422,345)

Abstract:

Loading...

Nasopharyngeal Carcinoma, anti-PD-1 antibody, Toripalimab

2.

Sequential Mr Ivim-Parametric As Potential Image Biomarkers In Evaluating the Radiosensitivity Of Human Nasopharyngeal Carcinoma Xenografts

Number of pages: 33 Posted: 14 Aug 2025
Fujian Medical University - Clinical Oncology School, affiliation not provided to SSRN, Fujian Provincial Cancer Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Fujian Medical University - Fujian Provincial Hospital and affiliation not provided to SSRN
Downloads 52 (1,041,696)

Abstract:

Loading...

Intravoxel incoherent motion, Magnetic resonance imaging, Diffusion weighted imaging, Pathological features, Nasopharyngeal carcinoma, Xenograft model.